Asset Details
Do you wish to reserve the book?
Optimizing similarity factor of in vitro drug release profile for development of early stage formulation of drug using linear regression model
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Optimizing similarity factor of in vitro drug release profile for development of early stage formulation of drug using linear regression model
Do you wish to request the book?
Optimizing similarity factor of in vitro drug release profile for development of early stage formulation of drug using linear regression model
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Optimizing similarity factor of in vitro drug release profile for development of early stage formulation of drug using linear regression model
2021
Overview
The objective of this article is to optimize the similarity factor within immediate release (IR) and modified release (MR) of in vitro drug release profiles. The least square method is used to minimize the difference between empirical and regression curve fitting data of in vitro IR/MR drug release profiles. An estimation of percentage drug release at intermediate timepoints has been done to improve the similarity factor f2 using linear curve fit method. In this study linear regression model is used to analyze the similarity factor f2 for Nitrofurantoin MR Capsules, Venlafaxine HCl MR Tablets and Lurasidone IR Tablets in order to exhibit the significance as well as similarity owing to the consideration of extra intervening timepoints. This linear regression model may help pharmaceutical industries to examine the inside comparison of IR/MR in vitro drug release profile with few modifications in timepoint selection to improve similarity factor f2.
Publisher
Springer Nature B.V
Subject
